Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Pharm Res
; 40(11): 2653-2666, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-38082089
Full text:
1
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
Limits:
Adolescent
/
Adult
/
Child
/
Humans
Language:
En
Year:
2023
Type:
Article